Views & Analysis Making the case for pharmaceutical IP management IP management can protect pharma companies’ investments and future R&D.
News Biogen protects Tecfidera via $1.25bn deal with Forward Biogen could also pay royalties to Forward.
Views & Analysis Recent trends in ANDA litigation Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
News NHS use of digital cardiac rehab tools endorsed Seven digital health technologies used to support people recovering from cardiovascular diseases have been recommended for use by the NHS.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
